** ASX-listed shares of Australia's AVITA Medical AVH.AX RCEL.O rise as much as 7.9% to A$4.11
** Stock set for strongest trading session since early Nov and hits highest since Dec. 12
** Co says U.S. Food and Drug Administration granted approval for its Recell Go mini product
** The product is a mini disposable cartridge designed to treat smaller wounds
** Stock had fallen 11.2% this year, as of last close
(Reporting by Rishav Chatterjee in Bengaluru)
((Rishav.Chatterjee@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。